SCHEMBL2858482

SCHEMBL2858482

CCCCCCCCCCCCCCCCC(C(=O)O)C(=O)C(CCCCCCCCCCCCCC)C(=O)C(O)CO

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.56
FFAR1 O14842 2/20 0.56
MAPT P10636 2/20 0.46
LCK P06239 1/20 0.46
PPARD Q03181 1/20 0.46
ZDHHC20 Q5W0Z9 1/20 0.46
ZDHHC2 Q9UIJ5 1/20 0.46
FFAR4 Q5NUL3 1/20 0.43
ACE2 Q9BYF1 1/20 0.43
LMNA P02545 2/20 0.42
CYP2D6 P10635 2/20 0.41
SPHK1 Q9NYA1 1/20 0.41
GMNN O75496 1/20 0.41
POLB P06746 1/20 0.41
THPO P40225 1/20 0.41
MTOR P42345 1/20 0.41
BLM P54132 1/20 0.41
KDM4E B2RXH2 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL168064 0.96 GPR84 (0.60) GPR84FFAR1MAPTLCKPPARD
SCHEMBL1237975 0.96 GPR84 (0.60) GPR84FFAR1MAPTLCKPPARD
SCHEMBL165537 0.96 GPR84 (0.60) GPR84FFAR1MAPTLCKPPARD
SCHEMBL167865 0.96 GPR84 (0.60) GPR84FFAR1MAPTLCKPPARD
SCHEMBL584656 0.96 GPR84 (0.60) GPR84FFAR1MAPTLCKPPARD
SCHEMBL167222 0.96 GPR84 (0.60) GPR84FFAR1MAPTLCKPPARD
SCHEMBL17646227 0.96 GPR84 (0.60) GPR84FFAR1MAPTLCKPPARD
SCHEMBL425589 0.96 GPR84 (0.60) GPR84FFAR1MAPTLCKPPARD
SCHEMBL5740376 0.95 GPR84 (0.57) GPR84FFAR1MAPTLCKPPARD
SCHEMBL6910867 0.92 GPR84 (0.55) GPR84FFAR1MAPTLCKPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1482915-B1 THERAPEUTIC SYSTEM FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS JAGOTEC AG (CH) 2010-01-13 EP disclosed
US-20050163845-A1 tablet comprising a nucleus coated with polymeric film, insoluble and impermeable to water including laser cut incisions delimiting an area having exactly programmable and defined dimensions and geometric shape; in biological fluids, the portion of film inside incision(s) detaches and releases drug JAGOTEC AG (CH) 2005-07-28 US disclosed
US-20050095295-A1 Therapeutic system for the controlled release of active ingredients JAGOTEC AG (CH) 2005-05-05 US disclosed
EP-1482915-A1 THERAPEUTIC SYSTEM FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS JAGOTEC AG (CH) 2004-12-08 EP disclosed
EP-1482913-A1 A SYSTEM FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS JAGOTEC AG (CH) 2004-12-08 EP disclosed
WO-2003075894-A1 A SYSTEM FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS JAGOTEC AG (CH) 2003-09-18 WO disclosed
WO-2003075897-A1 THERAPEUTIC SYSTEM FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS JAGOTEC AG (CH) 2003-09-18 WO disclosed